The Allstate Corporation (NYSE:ALL – Free Report) – Research analysts at Zacks Research reduced their Q4 2027 earnings per share estimates for Allstate in a report released on Wednesday, May 13th. Zacks Research analyst Team now anticipates that the insurance provider will post earnings of $7.37 per share for the quarter, down from their prior forecast of $7.58. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Allstate’s current full-year earnings is $28.82 per share. Zacks Research also issued estimates for Allstate’s Q1 2028 earnings at $6.93 EPS.
Several other equities research analysts also recently issued reports on ALL. Cantor Fitzgerald reiterated a “neutral” rating and issued a $220.00 price objective on shares of Allstate in a report on Thursday, February 5th. The Goldman Sachs Group reiterated a “neutral” rating and issued a $231.00 price objective on shares of Allstate in a report on Thursday, March 5th. Wells Fargo & Company boosted their target price on Allstate from $229.00 to $243.00 and gave the stock an “equal weight” rating in a research note on Wednesday, May 6th. Citigroup boosted their target price on Allstate from $221.00 to $226.00 and gave the stock a “neutral” rating in a research note on Friday, May 1st. Finally, Mizuho lowered their target price on Allstate from $281.00 to $265.00 and set an “outperform” rating for the company in a research note on Friday, March 20th. Three investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $241.67.
Allstate Price Performance
ALL stock opened at $215.35 on Thursday. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.25. The company has a market capitalization of $55.44 billion, a PE ratio of 4.75, a P/E/G ratio of 0.39 and a beta of 0.21. Allstate has a 12-month low of $188.08 and a 12-month high of $222.23. The business’s fifty day moving average price is $211.07 and its 200 day moving average price is $206.83.
Allstate (NYSE:ALL – Get Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.31 by $3.34. The firm had revenue of $16.94 billion for the quarter, compared to the consensus estimate of $15.24 billion. Allstate had a return on equity of 42.66% and a net margin of 17.81%.The company’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.53 EPS.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the business. South Plains Financial Inc. boosted its position in shares of Allstate by 41.5% during the 3rd quarter. South Plains Financial Inc. now owns 167 shares of the insurance provider’s stock worth $36,000 after acquiring an additional 49 shares in the last quarter. Coldstream Capital Management Inc. boosted its position in shares of Allstate by 0.6% in the 4th quarter. Coldstream Capital Management Inc. now owns 7,809 shares of the insurance provider’s stock valued at $1,625,000 after purchasing an additional 50 shares during the period. Compound Planning Inc. boosted its position in shares of Allstate by 1.6% in the 4th quarter. Compound Planning Inc. now owns 3,216 shares of the insurance provider’s stock valued at $669,000 after purchasing an additional 50 shares during the period. Humankind Investments LLC boosted its position in shares of Allstate by 4.5% in the 3rd quarter. Humankind Investments LLC now owns 1,191 shares of the insurance provider’s stock valued at $256,000 after purchasing an additional 51 shares during the period. Finally, Cullen Frost Bankers Inc. boosted its position in shares of Allstate by 0.9% in the 4th quarter. Cullen Frost Bankers Inc. now owns 5,815 shares of the insurance provider’s stock valued at $1,210,000 after purchasing an additional 52 shares during the period. 76.47% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In other news, COO Mario Rizzo sold 18,578 shares of the company’s stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $218.80, for a total transaction of $4,064,866.40. Following the completion of the transaction, the chief operating officer directly owned 82,227 shares of the company’s stock, valued at approximately $17,991,267.60. This represents a 18.43% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 1.55% of the company’s stock.
Allstate Company Profile
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
Featured Stories
- Five stocks we like better than Allstate
- Airplane Maintenance Companies That Keep Flights Moving Are Ready to Soar
- Oklo Stock Could Be Ready for Another Massive Run
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
